Article: Cancer Center Sets $3 Billion Program by Ron Wilslow. Wall Street Journal September 21, 2012
The M.D. Anderson Cancer Center in Houston TX is one of the world's leading cancer treatment and research centers, treating about 117,000 patients in 2011 and conducting some 1,000 clinical trials involving around 11,000 patients. Its $3 billion program is aimed at reducing cancer deaths over the next decade
The Center sees great opportunities for advancements in cancer treatment due to the plummeting cost of gene sequencing enabling precise targeting of genetic aberrations with specific drugs to address those aberrations. Also important will be vastly more powerful computers to analyze genomic data and enhanced ability to manipulate genes in laboratory experiments to understand the relationship of genes to tumors.
No comments:
Post a Comment